Sanofi launches diabetes drug Soliqua in India

May 02, 2024, at 03:13 am

Kolkata: Sanofi India Limited has launched its’ new diabetes drug Soliqua after having received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) earlier last year.

France's Sanofi accelerates plans, expects production of COVID-19 vaccine in early 2021

Jun 23, 2020, at 05:01 pm

Paris/Sputnik: French pharmaceutical giant Sanofi plans to start clinical trials of the COVID-19 vaccine developed in collaboration with the British drugmaker GSK in September and seeks to release the vaccine on sale in the first half of 2021, which is earlier than first anticipated, the Sanofi company announced on Tuesday.

Sanofi and Regeneron announce FDA approval of Dupixent

Mar 30, 2017, at 05:11 am

Mumbai/Kolkata, Mar 29 (IBNS): Sanofi and Regeneron Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Dupixent (dupilumab) Injection, the first and only biologic medicine approved for the treatment of adults with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable.

First dengue vaccine approved in more than 10 countries

Oct 04, 2016, at 11:08 pm

Kolkata/Lyon, Oct 4 (IBNS): Sanofi Pasteur, the vaccines global business unit of Sanofi, announced on Tuesday that Dengvaxia dengue vaccine has now received its 11th marketing approval, four of which granted from Regulatory Authorities recognized by the World Health Organization (WHO).

Sanofi, Medtronic to form strategic alliance in diabetes

Jun 17, 2014, at 04:49 am

Paris , June 16 (IBNS) Sanofi and Medtronic, Inc. on Monday announced that they have signed a memorandum of understanding to enter into a global strategic alliance in diabetes, aimed at improving patient experience and outcomes for people with diabetes around the world.